Pet-radiomics in lymphoma and multiple myeloma: update of current literature
Authors:
- 13 November 2023
- journal article
- review article
- Published by Springer Nature in Clinical and Translational Imaging
- Vol. 12 (2) , 119-135
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin LymphomaJournal of Clinical Oncology, 2017
- Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCLEuropean Journal of Nuclear Medicine and Molecular Imaging, 2016
- Improving the efficacy of mammography screening: the potential and challenge of developing new computer-aided detection approachesExpert Review of Medical Devices, 2015
- ibex: An open infrastructure software platform to facilitate collaborative work in radiomicsMedical Physics, 2015
- Positron emission tomography-adapted therapy for first-line treatment in individuals with Hodgkin lymphomaCochrane Database of Systematic Reviews, 2015
- Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano ClassificationJournal of Clinical Oncology, 2014
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working GroupJournal of Clinical Oncology, 2014
- Radiomics in PET: principles and applicationsClinical and Translational Imaging, 2014
- Baseline metabolic tumour volume is an independent prognostic factor in Hodgkin lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Metabolic tumor volume by positron emission tomography/computed tomography as a clinical parameter to determine therapeutic modality for early stage Hodgkin's lymphomaCancer Science, 2013